Business · 12/08/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Gastrointestinal Drugs Advisory Committee for OCALIVA Supplemental New Drug Application
Summary
The FDA is hosting a public meeting of the Gastrointestinal Drugs Advisory Committee to provide advice on a supplemental new drug application for OCALIVA (obeticholic acid) Oral Tablets, and is seeking public comments on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →